In the granulocytes of patients with CML, treatment with NAC induced phosphorylation of mTOR, indicating redox sensitivity of the kinase (p < 0.05, Figure 4b). This evidence concerns the gene MTOR and chronic myelogenous leukemia, BCR-ABL1 positive.